Studies Peptides Calculator

Pepdox aggregates peer-reviewed research from PubMed. This site is for informational purposes only.

Built by Thorne

Glossary Privacy Policy

Home
Search
PMID 42035775

Semaglutide, weight loss, and cardiovascular outcomes in the SELECT trial.

Lancet (London, England)2026PMID: 42035775

View on PubMed DOI: 10.1016/S0140-6736(26)00256-4

Authors

Tondt, Justin; Chinchilli, Vernon M

Semaglutide, weight loss, and cardiovascular outcomes in the SELECT trial. | Pepdox